Modified GRF 1-29
CJC-1295 No DAC
Short-acting GHRH analogue for pulsatile growth hormone research.
Complete guide to CJC-1295 No DAC in AustraliaPrices in AUD. Tax included.
Research Use Only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.
Description
CJC-1295 without DAC (Modified GRF 1-29) is a growth hormone-releasing hormone analogue used in research protocols studying pulsatile GH secretion. Its shorter half-life compared to the DAC variant makes it suitable for protocols requiring discrete GH pulse stimulation.
Specifications
- SKU
- CJCNODAC-10MG
- Size
- 10 mg
- Form
- Lyophilised Powder
- Purity
- >99%
- Storage
- -20°C (lyophilised), 2-8°C (reconstituted)
- Shipping
- Australia Post — 3–5 business days
Research Summary
Research demonstrates CJC-1295 (no DAC) stimulates GH release via GHRH receptor activation with a half-life of approximately 30 minutes, producing discrete GH pulses rather than sustained elevation. It is commonly studied in combination with selective GHRPs for synergistic GH output.
Testing Protocol
- HPLC Purity Analysis
- Mass Spectrometry Identity Verification
- Endotoxin Screening (LAL Test)